NCT02293044

Brief Summary

This study will compare the safety and effectiveness of a potassium oxalate desensitizer on adjacent teeth with dentinal hypersensitivity.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2014

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2014

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2014

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

November 7, 2014

Completed
11 days until next milestone

First Posted

Study publicly available on registry

November 18, 2014

Completed
4.5 years until next milestone

Results Posted

Study results publicly available

May 21, 2019

Completed
Last Updated

June 25, 2019

Status Verified

June 1, 2019

Enrollment Period

Same day

First QC Date

November 7, 2014

Results QC Date

April 26, 2019

Last Update Submit

June 13, 2019

Conditions

Keywords

Sensitivity

Outcome Measures

Primary Outcomes (1)

  • Change From Baseline Cold Water Challenge

    The Schiff Sensitivity Scale was assessed for each test tooth via a cold water challenge. The examiner recorded the Schiff Index score corresponding to the response to the cold water challenge. The Schiff Index Sensitivity scale is scored as follows- 0: tooth/subject did not respond to stimulus, 1: tooth/subject responds to stimulus, but does not request discontinuation of stimulus, 2: tooth/subject responds to stimulus and requests discontinuation or moves form stimulus, 3: tooth/subject responds to stimulus, considers stimulus to be painful, and requests discontinuation of the stimulus. A negative change from Baseline score represents a decrease in sensitivity from baseline. The mean change from Baseline was calculated for this measure.

    1 Day

Secondary Outcomes (1)

  • Change From Baseline Visual Analog Scale

    1 Day

Study Arms (1)

Crest® Sensi-Stop™ Strips

EXPERIMENTAL

Self Applied

Device: Crest® Sensi-Stop™ Strips

Interventions

Crest® Sensi-Stop™ Strips

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • be at least 18 years of age
  • sign an informed consent form and be given a copy
  • be in good general health as determined by the Investigator/designee
  • have at least one pair of adjacent teeth, each of which has a screening score of - -greater than or equal to 1 on the Schiff Sensitivity Scale in response to the cold water challenge.

You may not qualify if:

  • severe periodontal disease, as characterized by purulent exudate, generalized mobility, and/or severe recession
  • active treatment for periodontitis
  • any diseases or conditions that might interfere with the subject safely completing the study
  • inability to undergo study procedures
  • fixed facial orthodontic appliances
  • self-reported pregnancy or nursing
  • a history of kidney stones
  • known allergies to the following ingredients; aqua, glycerin, cellulose gum, dipotassium oxalate, carbomer, sodium hydroxide, sodium benzoate, and potassium sorbate.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oral Health Science Center

Mason, Ohio, 45040, United States

Location

MeSH Terms

Conditions

Dentin SensitivityHypersensitivity

Condition Hierarchy (Ancestors)

Tooth DiseasesStomatognathic DiseasesImmune System Diseases

Results Point of Contact

Title
Clinical Trial Manager
Organization
The Procter & Gamble Company

Study Officials

  • Robert W Gerlach, DDS, MPH

    Procter and Gamble

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 7, 2014

First Posted

November 18, 2014

Study Start

November 1, 2014

Primary Completion

November 1, 2014

Study Completion

November 1, 2014

Last Updated

June 25, 2019

Results First Posted

May 21, 2019

Record last verified: 2019-06

Locations